Annual Cash & Cash Equivalents
$1.90 B
-$1.21 B-38.78%
31 December 2023
Summary:
VEON annual cash & cash equivalents is currently $1.90 billion, with the most recent change of -$1.21 billion (-38.78%) on 31 December 2023. During the last 3 years, it has fallen by -$350.00 million (-15.54%). VEON annual cash & cash equivalents is now -70.01% below its all-time high of $6.34 billion, reached on 31 December 2014.VEON Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
N/A
01 September 2024
Summary:
VEON quarterly cash and cash equivalents is not available.VEON Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VEON Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -15.5% | - |
| 5 y5 years | +52.2% | - |
VEON Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.8% | at low | ||
| 5 y | 5 years | -38.8% | +52.2% | ||
| alltime | all time | -70.0% | +114.9% |
VEON Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $862.00 M(-54.7%) |
| Dec 2023 | $1.90 B(-38.8%) | $1.90 B(-22.6%) |
| June 2023 | - | $2.46 B(+5.0%) |
| Dec 2022 | $3.11 B(+38.0%) | - |
| June 2022 | - | $2.34 B(+3.9%) |
| Dec 2021 | $2.25 B(+34.9%) | $2.25 B(+50.3%) |
| Sept 2021 | - | $1.50 B(+25.7%) |
| June 2021 | - | $1.19 B(-0.1%) |
| Mar 2021 | - | $1.19 B(-28.5%) |
| Dec 2020 | $1.67 B(+33.5%) | $1.67 B(+54.4%) |
| Sept 2020 | - | $1.08 B(-7.3%) |
| June 2020 | - | $1.17 B(-21.5%) |
| Mar 2020 | - | $1.49 B(+18.9%) |
| Dec 2019 | $1.25 B(-30.9%) | $1.25 B(-5.1%) |
| Sept 2019 | - | $1.32 B(-1.1%) |
| June 2019 | - | $1.33 B(+5.2%) |
| Mar 2019 | - | $1.26 B(-30.0%) |
| Dec 2018 | $1.81 B(+37.6%) | $1.81 B(-46.4%) |
| Sept 2018 | - | $3.37 B(+150.9%) |
| June 2018 | - | $1.34 B(-3.6%) |
| Mar 2018 | - | $1.39 B(+6.0%) |
| Dec 2017 | $1.31 B(-55.3%) | $1.31 B(-48.8%) |
| Sept 2017 | - | $2.56 B(-10.7%) |
| June 2017 | - | $2.87 B(+32.3%) |
| Mar 2017 | - | $2.17 B(-26.2%) |
| Dec 2016 | $2.94 B | $2.94 B(-20.1%) |
| Sept 2016 | - | $3.68 B(+1.3%) |
| June 2016 | - | $3.63 B(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $2.93 B(-19.0%) |
| Dec 2015 | $3.61 B(-43.0%) | $3.61 B(-8.0%) |
| Sept 2015 | - | $3.93 B(-6.9%) |
| June 2015 | - | $4.22 B(-35.1%) |
| Mar 2015 | - | $6.50 B(+2.5%) |
| Dec 2014 | $6.34 B(+42.4%) | $6.34 B(+8.4%) |
| Sept 2014 | - | $5.85 B(+6.3%) |
| June 2014 | - | $5.50 B(+21.3%) |
| Mar 2014 | - | $4.54 B(+1.9%) |
| Dec 2013 | $4.45 B(-10.0%) | $4.45 B(-8.9%) |
| Sept 2013 | - | $4.89 B(+7.4%) |
| June 2013 | - | $4.55 B(-18.2%) |
| Mar 2013 | - | $5.56 B(+12.4%) |
| Dec 2012 | $4.95 B(+112.9%) | $4.95 B(+52.7%) |
| Sept 2012 | - | $3.24 B(+12.4%) |
| June 2012 | - | $2.88 B(-28.5%) |
| Mar 2012 | - | $4.03 B(+73.5%) |
| Dec 2011 | $2.33 B(+162.7%) | $2.33 B(-32.5%) |
| Sept 2011 | - | $3.44 B(+7.9%) |
| June 2011 | - | $3.19 B(+71.7%) |
| Mar 2011 | - | $1.86 B(+109.9%) |
| Dec 2010 | $885.13 M(-38.8%) | $885.13 M(-64.1%) |
| Sept 2010 | - | $2.47 B(+4.9%) |
| June 2010 | - | $2.35 B(+53.8%) |
| Mar 2010 | - | $1.53 B(+5.7%) |
| Dec 2009 | $1.45 B(+58.2%) | $1.45 B |
| Dec 2008 | $914.68 M(-8.9%) | - |
| Dec 2007 | $1.00 B | - |
FAQ
- What is VEON annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for VEON?
- What is the all time high quarterly cash and cash equivalents for VEON?
What is VEON annual cash & cash equivalents?
The current annual cash & cash equivalents of VEON is $1.90 B
What is the all time high annual cash & cash equivalents for VEON?
VEON all-time high annual cash & cash equivalents is $6.34 B
What is the all time high quarterly cash and cash equivalents for VEON?
VEON all-time high quarterly cash and cash equivalents is $6.50 B